+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Raynauds Disease Drug"

Raynaud's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Raynaud's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Raynauds Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Raynauds Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Raynauds Disease - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Raynauds Disease - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 99 Pages
  • Global
From
From
Raynauds Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Raynauds Disease - Pipeline Review, H1 2018

  • Drug Pipelines
  • February 2018
  • 50 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Raynaud's Disease is a disorder of the blood vessels, primarily affecting the fingers and toes. It is characterized by episodic vasospasms, which cause the affected areas to become cold and numb. Treatment for Raynaud's Disease typically involves lifestyle modifications, such as avoiding cold temperatures and stress, as well as medications. Cardiovascular drugs are used to treat Raynaud's Disease, as they can help to reduce the frequency and severity of vasospasms. These drugs include calcium channel blockers, alpha blockers, and vasodilators. Calcium channel blockers work by blocking the influx of calcium into the cells, which helps to relax the blood vessels and reduce the frequency of vasospasms. Alpha blockers work by blocking the action of certain hormones, which can help to reduce the severity of vasospasms. Vasodilators work by widening the blood vessels, which can help to improve blood flow and reduce the frequency of vasospasms. Some companies in the Raynaud's Disease Drug market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more